We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NTD

News List

QUT discovers new anticoagulant drug target for Covid-19 pharmaceutical-technology
July 09, 2021
A research team at the Queensland University of Technology (QUT) in Australia has discovered a new binding site on the SARS-CoV-2 spike (S) protein, which could be used as a target for anticoagulant drugs.
Neural Tube Defect Prevalence 7.0 Per 10,000 in HIV-Exposed drugs
January 20, 2020
The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population ...
BioIVT examines link between HIV Integrase inhibitor drugs and NTD during pregnancy biospectrumasia
August 18, 2019
The research investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors and published in Drug Metabolism and Disposition (DMD)